Page 2 - Genzyme Sanofi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A blood-based marker of mitochondrial DNA damage in Parkinson s disease | Science Translational Medicine

A blood-based marker of mitochondrial DNA damage in Parkinson s disease | Science Translational Medicine
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United statesBlue rockVanqua bioResolight rocheGenzyme sanofiScience centerScientist office senior clinical academic fellowshipCritical path for parkinson consortiumEthical committeeGraphpad prism softwarePepper centerBusch biomedical researchDuke university of memory disorders clinicMetabolism seed grant programNational neurological institutec mondinoResearch council of australia leadership fellowship

Bob Dagher: Promoting Teamwork to Bring BrainStorm Across the Finish Line

As the new executive VP and chief development officer of BrainStorm, Dagher is tasked with securing FDA approval of NurOwn for the treatment of ALS.

Boston university medical centerUnited statesBob dagherGenzyme sanofiBordeaux universityBrainstorm cellNorth americaOb dagher promoting teamwork to bring brainstorm across the finish line

Study Evaluates Pregnancy Risks With Biologics for Psoriasis

Use of biologics to treat psoriasis during pregnancy and/or at the time of conception was not associated with a higher rate of miscarriages or birth defects in a new meta-analysis.

United statesPalo altoSan franciscoEli lillyGenzyme sanofiDermatol venereolLeo pharmaJenny muraseBiomedical researchPalo alto medical foundationJournal of the european academy dermatologyAlicante institute for healthUniversity of californiaAlicante instituteEuropean academyGeneral population

RNA Based Therapeutic Market Trend 2023: Anticipated Growth to Reach $25 12 Billion by 2030 | 17 6%

According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investme.

United statesAsia pacificPawan kumarGenzyme sanofiOligonucleotides asosAlnylam pharmaceuticalsBenitec biopharma incBiotechnology companiesAlnylam pharmaceuticals incResearch institutesBusiness intelligence solutionsMarket researchArbutus biopharma corporationIonis pharmaceuticalsGradalis incBiogen inc

Precision Optics Appoints Wayne Coll as Chief Financial Officer

/PRNewswire/ Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and.

United statesUniversity of massachusettsJoe forkeyKevin dahillRobert blumGenzyme sanofiCompany contactLaboratory united statesOmicron solutionsUniversity of lowellPrecision optics corporationNational dentex corporationPrnewswire precision optics corporation incFlowonix medical incorporatedOptics corporationWayne coll